Postmastectomy radiotherapy in T1-2 patients with one to three positive lymph nodes–past, present and future
F Kaššák, C Rossier, C Picardi, J Bernier - The Breast, 2019 - Elsevier
Past The role of post-mastectomy radiotherapy (PMRT) in patients with tumor< 5 cm and one
to three positive lymph nodes after axillary dissection (ALND) is vigorously debated. Initial …
to three positive lymph nodes after axillary dissection (ALND) is vigorously debated. Initial …
Improvement of survival with postmastectomy radiotherapy in patients with 1-3 positive axillary lymph nodes: A systematic review and meta-analysis of the current …
H Headon, A Kasem… - Molecular and …, 2016 - spandidos-publications.com
In breast cancer with> 4 positive axillary lymph nodes, it is common practice to deliver
radiotherapy to the affected site following mastectomy. However, less is known regarding the …
radiotherapy to the affected site following mastectomy. However, less is known regarding the …
Selection criteria for postmastectomy radiotherapy in t1–t2 tumors with 1 to 3 positive lymph nodes
TA Moo, R McMillan, M Lee, M Stempel, S Patil… - Annals of surgical …, 2013 - Springer
Background Postmastectomy radiotherapy (PMRT) is well established in patients with≥ 4
positive axillary lymph nodes (ALN); indications in 1 to 3 positive ALN remains controversial …
positive axillary lymph nodes (ALN); indications in 1 to 3 positive ALN remains controversial …
Postmastectomy radiation therapy in women with T1-T2 tumors and 1 to 3 positive lymph nodes: analysis of the breast international group 02-98 trial
Purpose To analyze the impact of postmastectomy radiation therapy (PMRT) for patients with
T1-T2 tumors and 1 to 3 positive lymph nodes enrolled on the Breast International Group …
T1-T2 tumors and 1 to 3 positive lymph nodes enrolled on the Breast International Group …
[HTML][HTML] The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects
A Wöckel, R Wolters, T Wiegel, I Novopashenny… - Annals of oncology, 2014 - Elsevier
Background Radiotherapy (RT) is proven to be an important backbone for adjuvant therapy
in randomized, controlled trials, but it is unclear if these effects are provable in a daily routine …
in randomized, controlled trials, but it is unclear if these effects are provable in a daily routine …
Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the …
C Tausch, S Taucher, P Dubsky, M Seifert… - Annals of surgical …, 2012 - Springer
Purpose The number of removed axillary lymph nodes and the ratio of involved to removed
lymph nodes are described as independent prognostic factors beside the absolute number …
lymph nodes are described as independent prognostic factors beside the absolute number …
Post-mastectomy radiotherapy for breast cancer patients with T1-T2 and 1-3 positive lymph nodes: a meta-analysis
Background The role of post-mastectomy radiotherapy (PMRT) in patients with T1-2 and 1-3
positive lymph nodes remains controversial. The aim of this study is to investigate the …
positive lymph nodes remains controversial. The aim of this study is to investigate the …
Locoregional recurrence risk for postmastectomy breast cancer patients with T1–2 and one to three positive lymph nodes receiving modern systemic treatment without …
SF Lai, YH Chen, WH Kuo, HC Lien, MY Wang… - Annals of surgical …, 2016 - Springer
Background Administering postmastectomy radiotherapy (PMRT) to patients with T1–2
breast cancer and one to three positive axillary lymph nodes (ALNs) is controversial. The …
breast cancer and one to three positive axillary lymph nodes (ALNs) is controversial. The …
Multidisciplinary management of the axilla in patients with cT1-T2 N0 breast cancer undergoing primary mastectomy: results from a prospective single-institution series
S Grossmith, A Nguyen, J Hu, JK Plichta… - Annals of Surgical …, 2018 - Springer
Background The after mapping of the axilla: radiotherapy or surgery (AMAROS) trial
concluded that for patients with cT1-2 N0 breast cancer and one or two positive sentinel …
concluded that for patients with cT1-2 N0 breast cancer and one or two positive sentinel …
Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes
ZY He, SG Wu, J Zhou, FY Li, Q Lin, HX Lin, JY Sun - PloS one, 2015 - journals.plos.org
Objectives The indications for post-mastectomy radiotherapy (PMRT) with T1-2 breast
cancer and 1-3 positive axillary lymph nodes is still controversial. The purpose of this study …
cancer and 1-3 positive axillary lymph nodes is still controversial. The purpose of this study …